Published in Cardiovascular Business Week, July 5th, 2005
CEA "remains the gold standard for treatment of carotid stenosis," vascular surgeons in the United States explained. "With inevitable comparisons of catheter-based therapy to all aspects of CEA," a "study of a large contemporary series was undertaken to evaluate the determinants of anatomic durability of CEA."
"During the interval (1989 through 1999), 2,127 primary, isolated CEAs with selective patching (50.2%) were performed in 1,853 patients (61.8% male, 36.1% symptomatic)," according to G.M. Lamuraglia and colleagues at Harvard...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.